Sequence variation in hepatitis C viral isolates.

The single stranded, RNA genome of the hepatitis C (HCV) virus was characterized after approximately a decade of research in the field of non-A, non-B hepatitis (NANBH) (1, reviewed in Refs. 2 and 3). Since 1987, three genomes encoding the 3010-3011 amino acid putative precursor polyprotein (4-6) and numerous partial nucleotide sequences have been reported (reviewed in Refs. 7 and 8). Based on a comparison of the sequences available to date, Houghton et al. proposed that there are at least three groups of closely related HCV viruses (7). Of the two groups for which the nearly full-length genome has been determined (I :jk Ir;, KWI~WXS within a group appear to be 92% (95%) identical in the nucleotide (amino acid) sequence; while the overall percent nucleotide (amino acid) homology between groups is 7879% (85%). The range of deduced amino acid sequence homology in specific HCV proteins may be greater or lesser than the average over the entire putative polyprotein. For example, the putative nucleocapsid protein (Fig. 1) appears to be the most highly conserved protein both between members of the same group and between different groups (98-100% and 97-98%, respectively) (Refs. 7, 9 and 10, also see Fig. 2) and has therefore been especially useful for immunological (11-15) and hybridization based diagnostic tests for HCV (16). In contrast, the putative envelope glycoprotein El (gp33) is greater than 90% conserved in the amino acid sequence of isolates within a group but is only approx. 77-81% conserved between groups I and II (reviewed in Ref. 7; also see Fig. 3). The deduced amino acid sequence of the putative NS2 protein appears to be the most heteroge5 3 I I I I

[1]  H. Okamoto,et al.  The 5'-terminal sequence of the hepatitis C virus genome. , 1990, The Japanese journal of experimental medicine.

[2]  S. Zebedee,et al.  Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[4]  M. Houghton,et al.  Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.

[5]  J. Hoofnagle,et al.  Viral hepatitis and liver disease , 1984 .

[6]  M. Houghton,et al.  The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. , 1990, The Journal of general virology.

[7]  M. Houghton,et al.  A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. , 1989, Nucleic acids research.

[8]  Michael Ruogu Zhang,et al.  Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Purcell,et al.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Y. Matsuura,et al.  Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Giorgio,et al.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Sugimura,et al.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Matthew J. Brauer,et al.  Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.

[14]  N. Enomoto,et al.  There are two major types of hepatitis C virus in Japan. , 1990, Biochemical and biophysical research communications.

[15]  H. Okayama,et al.  Structure and organization of the hepatitis C virus genome isolated from human carriers , 1991, Journal of virology.

[16]  N. Kato,et al.  Hypervariable regions in the putative glycoprotein of hepatitis C virus. , 1991, Biochemical and biophysical research communications.

[17]  Matthew J. Brauer,et al.  Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Barr,et al.  Genetic organization and diversity of the hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Houghton,et al.  Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis. , 1990, Gene.

[20]  G. Vyas,et al.  Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. , 1990, The Journal of clinical investigation.

[21]  M. Houghton,et al.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay , 1991, The Lancet.

[22]  M. Houghton,et al.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. , 1990, British medical bulletin.